Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis

Peer Review reports

Original Submission
30 Oct 2020	Submitted	Original manuscript
7 Dec 2020	Reviewed	Reviewer Report
27 Dec 2020	Reviewed	Reviewer Report
25 Jan 2021	Author responded	Author comments - Katharina Nickel
Resubmission - Version 2
25 Jan 2021	Submitted	Manuscript version 2
Publishing
28 Jan 2021	Editorially accepted
26 Feb 2021	Article published	10.1186/s12879-021-05850-0

Back to article page